| abstract |
Cerebrovascular disorders (cerebrovascular obstruction, cerebral infarction, cerebral thrombosis, cerebral embolism, cerebral attack, cerebral hemorrhage, Willis' circle occlusion, cerebrovascular dementia, Alzheimer's dementia, etc.) can be efficaciously treated or prevented by transferring an HGF (hepatocyte growth factor) gene and/or a VEGF (vascular endothelial growth factor) gene into the subarachnoidal space of humans. |